BACKGROUND: A new annuloplasty device, the Colvin-Galloway Future Band, has been developed to allow simple and safe mitral valve repair surgery. Here we report its clinical use and the clinical results after a short-term, 2-year follow-up. METHODS: We assessed the performance of this new device in 40 consecutive patients (55% male; mean age, 68.3 +/- 8.1 years) who were operated on for mitral valve incompetence between 2001 and 2002. Ninety percent of these patients had associated surgical procedures. Clinical and echocardiographic assessment was performed perioperatively and at a mean follow-up of 16.5 +/- 5.7 months (range, 6 to 25 months) in all patients (100%), permitting analysis of 55 patient-years. RESULTS: Thirty-eight patients survived surgery, resulting in an overall early mortality of 5.0%. There were four noncardiac-related late deaths, resulting in an overall late mortality of 10.0%. Perioperative echocardiography showed no incidences of systolic anterior movement at the time of discharge from the hospital and satisfactory mitral repair results in 36 (95%) patients. At the time of the 2-year follow-up, echocardiography showed satisfactory mitral valve function in all but 2 patients (94%) and a significant postoperative ventricular remodeling: the left ventricular end-diastolic diameter decreased from 64.5 +/- 6.2 mm preoperatively to 50.4 +/- 9.5 mm postoperatively (p < 0.1). At the time of follow-up, 29 (90.6%) patients were in New York Heart Association functional class I or II, all of them describing their quality of life as "significantly improved" if compared with their preoperative status. There were no late reoperations and no thromboembolic, bleeding, or other complications. CONCLUSIONS: The clinical results of the Colvin-Galloway Future Band in this short-term follow-up of patients undergoing complex mitral valve repair seem to be promising.
BACKGROUND: A new annuloplasty device, the Colvin-Galloway Future Band, has been developed to allow simple and safe mitral valve repair surgery. Here we report its clinical use and the clinical results after a short-term, 2-year follow-up. METHODS: We assessed the performance of this new device in 40 consecutive patients (55% male; mean age, 68.3 +/- 8.1 years) who were operated on for mitral valve incompetence between 2001 and 2002. Ninety percent of these patients had associated surgical procedures. Clinical and echocardiographic assessment was performed perioperatively and at a mean follow-up of 16.5 +/- 5.7 months (range, 6 to 25 months) in all patients (100%), permitting analysis of 55 patient-years. RESULTS: Thirty-eight patients survived surgery, resulting in an overall early mortality of 5.0%. There were four noncardiac-related late deaths, resulting in an overall late mortality of 10.0%. Perioperative echocardiography showed no incidences of systolic anterior movement at the time of discharge from the hospital and satisfactory mitral repair results in 36 (95%) patients. At the time of the 2-year follow-up, echocardiography showed satisfactory mitral valve function in all but 2 patients (94%) and a significant postoperative ventricular remodeling: the left ventricular end-diastolic diameter decreased from 64.5 +/- 6.2 mm preoperatively to 50.4 +/- 9.5 mm postoperatively (p < 0.1). At the time of follow-up, 29 (90.6%) patients were in New York Heart Association functional class I or II, all of them describing their quality of life as "significantly improved" if compared with their preoperative status. There were no late reoperations and no thromboembolic, bleeding, or other complications. CONCLUSIONS: The clinical results of the Colvin-Galloway Future Band in this short-term follow-up of patients undergoing complex mitral valve repair seem to be promising.
Authors: Salma Ayoub; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Frederick J Schoen; Michael S Sacks Journal: Compr Physiol Date: 2016-09-15 Impact factor: 9.090
Authors: Khurram Owais; Han Kim; Kamal R Khabbaz; Remco Bergman; Robina Matyal; Robert C Gorman; Joseph H Gorman; Philip E Hess; Feroze Mahmood Journal: Ann Thorac Surg Date: 2014-03-06 Impact factor: 4.330
Authors: Molly F Purser; Andrew L Richards; Richard C Cook; Jason A Osborne; Denis R Cormier; Gregory D Buckner Journal: Ann Biomed Eng Date: 2010-07-23 Impact factor: 3.934
Authors: Molly F Purser; Andrew L Richards; Richard C Cook; Jason A Osborne; Denis R Cormier; Gregory D Buckner Journal: Ann Thorac Surg Date: 2009-10 Impact factor: 4.330
Authors: Chad E Eckert; Brett Zubiate; Mathieu Vergnat; Joseph H Gorman; Robert C Gorman; Michael S Sacks Journal: Ann Biomed Eng Date: 2009-07-08 Impact factor: 3.934